Prevalence and Characteristics of Metabolic Hyperferritinemia in a Population-Based Central-European Cohort

Sophie Gensluckner, Bernhard Wernly (Co-Autor/-in), Florian Koutny, Georg Strebinger, Stephan Zandanell (Co-Autor/-in), Lars Stechemesser (Co-Autor/-in), Bernhard Paulweber (Co-Autor/-in), Bernhard Iglseder (Co-Autor/-in), Eugen Trinka (Co-Autor/-in), Vanessa Frey (Co-Autor/-in), Patrick Langthaler (Co-Autor/-in), Georg Semmler, Luca Valenti, Elena Corradini, Christian Datz, Elmar Aigner* (Letztautor/-in)

*Korrespondierende/r Autor/-in für diese Arbeit

Publikation: Beitrag in FachzeitschriftOriginalarbeitBegutachtung

3 Quellenangaben (Web of Science)

Abstract

BACKGROUND: Hyperferritinemia (HF) is a common finding and can be considered as metabolic HF (MHF) in combination with metabolic diseases. The definition of MHF was heterogenous until a consensus statement was published recently. Our aim was to apply the definition of MHF to provide data on the prevalence and characteristics of MHF in a Central-European cohort.

METHODS: This study was a retrospective analysis of the Paracelsus 10,000 study, a population-based cohort study from the region of Salzburg, Austria. We included 8408 participants, aged 40-77. Participants with HF were divided into three categories according to their level of HF and evaluated for metabolic co-morbidities defined by the proposed criteria for MHF.

RESULTS: HF was present in 13% (n = 1111) with a clear male preponderance (n = 771, 69% of HF). Within the HF group, 81% (n = 901) of subjects fulfilled the metabolic criteria and were defined as MHF, of which 75% (n = 674) were characterized by a major criterion. In the remaining HF cohort, 52% (n = 227 of 437) of subjects were classified as MHF after application of the minor criteria.

CONCLUSION: HF is a common finding in the general middle-aged population and the majority of cases are classified as MHF. The new classification provides useful criteria for defining MHF.

OriginalspracheEnglisch
Seitenumfang13
FachzeitschriftBIOMEDICINES
Jahrgang12
Ausgabenummer1
DOIs
PublikationsstatusVeröffentlicht - 17 Jan. 2024

Fingerprint

Untersuchen Sie die Forschungsthemen von „Prevalence and Characteristics of Metabolic Hyperferritinemia in a Population-Based Central-European Cohort“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren